Topical Treatment for Inflammatory Bowel Disease Pouchitis Starts Pivotal Phase 3 Trial, Now Enrolling Patients

Topical Treatment for Inflammatory Bowel Disease Pouchitis Starts Pivotal Phase 3 Trial, Now Enrolling Patients
Atlantic Healthcare plc announced that it is now enrolling patients in a Phase 3 clinical trial to assess alicaforsen enema for the treatment of inflammatory bowel disease (IBD) pouchitis. Pouchitis, the inflammation of the ileal pouch (an artificial rectum surgically created out of ileal gut tissue in patients who have undergone a colectomy), currently has no approved treatment medications. Atlantic Healthcare is

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *